J R Lopez1, V Kaura2, C P Diggle2, P M Hopkins3, P D Allen4. 1. Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Molecular Biosciences, School of Veterinary Medicine, University of California at Davis, Davis, CA, USA. 2. Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, UK. 3. Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, UK; Malignant Hyperthermia Investigation Unit, St James' University Hospital, Leeds, UK. 4. Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Molecular Biosciences, School of Veterinary Medicine, University of California at Davis, Davis, CA, USA; Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, UK. Electronic address: p.d.allen@leeds.ac.uk.
Abstract
BACKGROUND: The human p.G2434R variant of the RYR1 gene is most frequently associated with malignant hyperthermia (MH) in the UK. We report the phenotype of a knock-in mouse that expresses the RYR1 variant p.G2435R, which is isogenetic with the human variant. METHODS: We observed the general phenotype; determined the sensitivity of myotubes to caffeine-, KCl, and halothane-induced Ca2+ release; determined the in vivo response to halothane or increased ambient temperature; and determined the in vivo myoplasmic intracellular Ca2+ concentration in skeletal muscle before and during exposure to volatile anaesthetics. RESULTS: RYR1 pG2435R/MH normal (MHS-Heterozygous[Het]) or RYR1 pG2435R/pG2435R (MHS-Homozygous[Hom]) mice were fully viable under typical rearing conditions, although some male MHS-Hom mice died spontaneously. The normalised half-maximal effective concentration (95% confidence interval) for intracellular Ca2+ release in myotubes in response to KCl [MH normal, MHN, 21.4 (19.8-23.1) mM; MHS-Het 16.2 (15.2-17.2) mM; MHS-Hom 11.2 (10.2-12.2) mM] and caffeine (MHN, 5.7 (5-6.3) mM; MHS-Het 4.5 (3.9-5.0) mM; MHS-Hom 1.77 (1.5-2.1) mM] exhibited a gene dose-dependent decrease, and there was a gene dose-dependent increase in halothane sensitivity. Intact animals show a gene dose-dependent susceptibility to MH with volatile anaesthetics or to heat stroke. RYR1 p.G2435R mice had elevated skeletal muscle intracellular resting [Ca2+]i, (values are expressed as mean (SD)) (MHN 123 (3) nM; MHS-Het 156 (16) nM; MHS-Hom 265 (32) nM; P<0.001) and [Na+]i (MHN 8 (0.1) mM; MHS-Het 10 (1) mM; MHS-Hom 14 (0.7) mM; P<0.001) that was further increased by exposure to volatile anaesthetics. CONCLUSIONS: RYR1 pG2435R mice demonstrated gene dose-dependent in vitro and in vivo responses to pharmacological and environmental stressors that parallel those seen in patients with the human RYR1 variant p.G2434R.
BACKGROUND: The humanp.G2434R variant of the RYR1 gene is most frequently associated with malignant hyperthermia (MH) in the UK. We report the phenotype of a knock-in mouse that expresses the RYR1 variant p.G2435R, which is isogenetic with the human variant. METHODS: We observed the general phenotype; determined the sensitivity of myotubes to caffeine-, KCl, and halothane-induced Ca2+ release; determined the in vivo response to halothane or increased ambient temperature; and determined the in vivo myoplasmic intracellular Ca2+ concentration in skeletal muscle before and during exposure to volatile anaesthetics. RESULTS:RYR1 pG2435R/MH normal (MHS-Heterozygous[Het]) or RYR1 pG2435R/pG2435R (MHS-Homozygous[Hom]) mice were fully viable under typical rearing conditions, although some male MHS-Hom mice died spontaneously. The normalised half-maximal effective concentration (95% confidence interval) for intracellular Ca2+ release in myotubes in response to KCl [MH normal, MHN, 21.4 (19.8-23.1) mM; MHS-Het 16.2 (15.2-17.2) mM; MHS-Hom 11.2 (10.2-12.2) mM] and caffeine (MHN, 5.7 (5-6.3) mM; MHS-Het 4.5 (3.9-5.0) mM; MHS-Hom 1.77 (1.5-2.1) mM] exhibited a gene dose-dependent decrease, and there was a gene dose-dependent increase in halothane sensitivity. Intact animals show a gene dose-dependent susceptibility to MH with volatile anaesthetics or to heat stroke. RYR1p.G2435Rmice had elevated skeletal muscle intracellular resting [Ca2+]i, (values are expressed as mean (SD)) (MHN 123 (3) nM; MHS-Het 156 (16) nM; MHS-Hom 265 (32) nM; P<0.001) and [Na+]i (MHN 8 (0.1) mM; MHS-Het 10 (1) mM; MHS-Hom 14 (0.7) mM; P<0.001) that was further increased by exposure to volatile anaesthetics. CONCLUSIONS:RYR1 pG2435R mice demonstrated gene dose-dependent in vitro and in vivo responses to pharmacological and environmental stressors that parallel those seen in patients with the humanRYR1 variant p.G2434R.
Authors: Jose Miguel Eltit; Roger A Bannister; Ong Moua; Francisco Altamirano; Philip M Hopkins; Isaac N Pessah; Tadeusz F Molinski; Jose R López; Kurt G Beam; Paul D Allen Journal: Proc Natl Acad Sci U S A Date: 2012-04-30 Impact factor: 11.205
Authors: Guo Guang Du; Bimal Sandhu; Vijay K Khanna; Xing Hua Guo; David H MacLennan Journal: Proc Natl Acad Sci U S A Date: 2002-12-16 Impact factor: 11.205
Authors: Francisco Altamirano; José M Eltit; Gaëlle Robin; Nancy Linares; Xudong Ding; Isaac N Pessah; Paul D Allen; José R López Journal: J Biol Chem Date: 2014-05-20 Impact factor: 5.157
Authors: Benjamin Yuen; Simona Boncompagni; Wei Feng; Tianzhong Yang; Jose R Lopez; Klaus I Matthaei; Samuel R Goth; Feliciano Protasi; Clara Franzini-Armstrong; Paul D Allen; Isaac N Pessah Journal: FASEB J Date: 2011-11-30 Impact factor: 5.191
Authors: Mihail G Chelu; Sanjeewa A Goonasekera; William J Durham; Wei Tang; John D Lueck; Joyce Riehl; Isaac N Pessah; Pumin Zhang; Meenakshi B Bhattacharjee; Robert T Dirksen; Susan L Hamilton Journal: FASEB J Date: 2005-11-11 Impact factor: 5.191
Authors: Jose Rafael Lopez; Vikas Kaura; Phillip Hopkins; Xiaochen Liu; Arkady Uryach; Jose Adams; Paul D Allen Journal: Anesthesiology Date: 2020-08 Impact factor: 7.892
Authors: Leon Chang; Xiaochen Liu; Christine P Diggle; John P Boyle; Philip M Hopkins; Marie-Anne Shaw; Paul D Allen Journal: J Biol Chem Date: 2020-08-21 Impact factor: 5.157
Authors: Leon Chang; Catherine Daly; Dorota M Miller; Paul D Allen; John P Boyle; Philip M Hopkins; Marie-Anne Shaw Journal: Br J Anaesth Date: 2019-03-20 Impact factor: 9.166
Authors: Monica Aleman; Rui Zhang; Wei Feng; Lihong Qi; Jose R Lopez; Chelsea Crowe; Yao Dong; Genady Cherednichenko; Isaac N Pessah Journal: Mol Pharmacol Date: 2020-08-06 Impact factor: 4.436